Sterile Injectable Drugs Market By Molecule Type (Small Molecule & Large Molecule), Drug Class (Monoclonal Antibodies (mAbs), Immunoglobulin, Vaccines, Blood Factors, Cytokines, Peptide Hormones & Insulin), Indication (Neurology, Oncology, Cardiovascular Diseases, Autoimmune Disorders, Musculoskeletal Disorders, Infectious Disorders & Cancer), Route of Administration (Subcutaneous (SC), Intravenous (IV) & Intramuscular (IM)), Distribution Channel (Hospital Pharmacy, Retail Pharmacy & E-Commerce) - Analysis & Forecast 2019-2030

Report ID : 165  |  Published Date : May 2020  |  Pages : 160  |  Region : Global  |  Report Code : PH-9





Sterile Injectable Drugs Market Overview and Introduction

Sterile injectable drugs are drug preparations containing active ingredients, which are injected into the body using syringes or needles. The drug and its preparations are available in sterile forms and are safe and effective for the treatment of diseases showing a low response to oral medications. These drugs assists in faster recovery from disease and can be used as an alternative in hospitals to conventional methods.

The sterile injectable market is driven by a rise in incidences & prevalence of diseases such as cancer and other chronic diseases. Moreover, fast-track approval of new drugs by FDA for the treatment of cancer and other chronic disease is also anticipated to boost the market during the forecast period. However, higher operational costs might act as a barrier to the global sterile injectable drugs market.

The sterile injectable drugs market is segmented by molecule type, drug class, indication, distribution channel, and region.

Sterile Injectable Drugs Market by Molecule Type

Based on molecule type, the sterile injectable drugs market is segmented into small molecule and large molecule. The large molecule segment is anticipated to account for the largest share during the forecast period.

Sterile Injectable Drugs Market by Drug Class

Based on drug class, the sterile injectable drugs market is segmented into monoclonal antibodies (mAbs), immunoglobulin, vaccines, blood factors, cytokines, peptide hormones & insulin. The monoclonal antibodies segment is anticipated to grow at a high CAGR followed by vaccines and insulin during the forecast period.

Sterile Injectable Drugs Market by Indication

On the basis of indication the sterile injectable drugs market is segmented into neurology, oncology, cardiovascular diseases, autoimmune disorders, musculoskeletal disorders, infectious disorders, and cancers. The cancers segment is anticipated to grow at a high CAGR owing to rising incidences of cancer cases worldwide.

Sterile Injectable Drugs Market by Route of Administration

Based on route of administration, the sterile injectable drugs market is segmented into subcutaneous (SC), intravenous (IV) and intramuscular (IM) and other route of administrations.

Sterile Injectable Drugs Market by Distribution Channel

Based on distribution channel, the sterile injectable drugs market is segmented into hospital pharmacy, retail pharmacy, and e-commerce. The hospital pharmacy segment is anticipated to grow at a high CAGR during the forecast period.

Sterile Injectable Drugs Market by Region

The sterile injectable drugs market can be segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America is anticipated to dominate the sterile injectable drugs market in 2019, owing to rising prevalence of chronic diseases and increasing R&D as well as clinical trials. Furthermore, increasing investments and developments in the healthcare sector are anticipated to boost the global sterile injectable drugs market.

Sterile Injectable Drugs Market Prominent Players

Some prominent players in the sterile injectable drugs market include Johnson & Johnson Services, Inc., Sanofi, Novo Nordisk A/S, Pfizer Inc., AstraZeneca, Merck & Co., Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Gilead Sciences, Inc. Baxter, and others.